A biochemical index much studied in recent years, the soluble fms-like tyrosine kinase-1/placental growth factor (sFlt1/PlGF) ratio, may be a valuable tool for initial assessment in patients with a TMA in pregnancy to rule out preeclampsia/HELLP syndrome. The gene discussed is FLT1; the disease is HELLP syndrome.